Notably, high ALDH1-expressing breast cancer cells survived chemotherapy/radiotherapy, relative to cells expressing low levels of ALDH1, and pre-treatment of cell populations with the ALDH inhibitor, diethylaminobenzaldehyde, resulted in significant initial sensitization of ALDH-expressing cells to chemotherapy or radiotherapy. The gene discussed is ALDH1A1; the disease is breast cancer.